Allergan, Inc. (NYSE: AGN)
| View: Annual | Quarterly | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Revenue | 3,041.0 | 1,972.2 | 1,563.5 |
| Cost of Goods Sold | 525.7 | 337.1 | 293.8 |
| Gross Profit | 2,515.3 | 1,635.1 | 1,269.7 |
| Gross Profit Margin | 82.7% | 82.9% | 81.2% |
| SG&A Expense | 1,281.8 | 841.2 | 680.6 |
| Depreciation & Amortization | 104.2 | 60.7 | 40.6 |
| Operating Income | 585.5 | 380.1 | 20.8 |
| Operating Margin | 19.3% | 19.3% | 1.3% |
| Nonoperating Income | 12.6 | (12.8) | (2.6) |
| Nonoperating Expenses | (18.7) | -- | -- |
| Income Before Taxes | 543.6 | 344.3 | (10.0) |
| Income Taxes | 143.0 | 93.2 | 54.9 |
| Net Income After Taxes | 400.7 | 251.1 | (64.8) |
| Continuing Operations | 399.6 | 250.9 | (65.0) |
| Discontinued Operations | 0.0 | (0.9) | -- |
| Total Operations | 399.6 | 250.0 | (65.0) |
| Total Net Income | 399.6 | 250.0 | (65.0) |
| Net Profit Margin | 13.1% | 12.7% | -- |
| Diluted EPS from Total Net Income (£) | 1.31 | 0.81 | (0.22) |
| Dividends per Share | 0.14 | 0.10 | 0.10 |
